ClariVest Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $1.24M | Sell |
|
|||||
|
2023
Q3 | $1.02M | Hold |
|
|||||
|
2023
Q2 | $1.17M | Buy |
|
|||||
|
2023
Q1 | $1.18M | Sell |
|
|||||
|
2022
Q4 | $1.33M | Sell |
|
|||||
|
2022
Q3 | $929K | Hold |
|
|||||
|
2022
Q2 | $507K | Hold |
|
|||||
|
2022
Q1 | $601K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $634K | Buy |
|
|||||
|
2020
Q4 | $434K | Sell |
|
|||||
|
2020
Q3 | $391K | Sell |
|
|||||
|
2020
Q2 | $645K | Sell |
|
|||||
|
2020
Q1 | $569K | Sell |
|
|||||
|
2019
Q4 | $588K | Sell |
|
|||||
|
2019
Q3 | $843K | Hold |
|
|||||
|
2019
Q2 | $610K | Buy |
|